findmyKOL

Guy Jones, MD

Basic profile

University of Nevada

ORCIDNone on fileNPI
RegionReno, NV · WestSpecialtyRadiation OncologyFocusOncology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Guy Jones is an Oncology physician affiliated with University of Nevada. OpenAlex indexes 24 publications with 548 citations (h-index 8).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
24publications

Distinct works indexed by OpenAlex.

548citations

Total citations across indexed works.

8h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
8companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Industry payments

8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

8 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Genitourinary & hormones

    39.6%
    alpha-Adrenergic Blocker36%
    Tamsulosin Hcl100%
    Part D61 patients
    beta3-Adrenergic Agonist3.6%
    Myrbetriq100%
    Part D<11 patients
  • Nervous system

    26.7%
    Benzodiazepine23.8%
    Alprazolam52%Lorazepam48%
    Part D47 patients
    Opioid Agonist2.8%
    Oxycodone Hcl100%
    Part D<11 patients
  • Sensory organs

    7.3%
    Fluoroquinolone Antibacterial7.3%
    Ciprofloxacin Hcl100%
    Part D28 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”